Table 1.
Inclusion and exclusion criteria of papers selected for this review.
| Criterion | Reason of inclusion | Reason of exclusion |
|---|---|---|
| Population | Qualifying disease: AD (diagnosed with established criteria, e.g., DSM-IV and NINCDS-ADRDA) Any severity of disease at baseline Community-/nursing-home-dwelling residents |
|
|
| ||
| Perspective of the study | Prospective (concurrent) Comparative |
Retrospective (nonconcurrent, historical) |
|
| ||
| Type of the study | RCT (open label or blinded) Crossover trials with a washout period between treatments |
Non-randomised CCT: cohort observational case control cross sectional noncomparative study |
|
| ||
| Language | English | All others |
|
| ||
| Study duration | Any | None |
|
| ||
| Sample size | Any | None |
|
| ||
| Intervention/treatments | Any dose of (i) donepezil (ii) memantine |
|
|
| ||
| Control intervention/treatments | Placebo/usual care Any of the above interventions |
|
DSM-IV: Diagnostic and Statistical Manual of Mental Disorders; NINCDS-ADRDA: National Institute of Neurological and Communicative Disorders and Stroke and the AD and Related Disorders Association; CCT: controlled clinical trial.